The Egyptian International Pharmaceutical Industries (EIPICO) has received four offers from banks to provide a EGP 800 mn loan to part finance its cancer treatment project dubbed EIPICO 3, Chairman Ahmed Kilani told Al Mal. The EGP 1.2 bn (pdf) project is the first of its kind in Egypt and will produce medical products to treat cancers and hormonal s
More from Enterprise
BdC’s 3Q net income falls 20% y-o-y, while 9M income rises 5%
Provisions more than doubled q-o-q to EGP 1.09 bn, dragging…
Africa’s own credit rating agency plans its first rating by March 2027, and our central bank has long backed it
Its early value lies in 22 sovereigns nobody rates, and…
EGX’s newest investors meet their first selloff
Heavy borrowing, margin calls, and looming repayments could make a…